Intervention

topiramate

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 18 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting0
Common conditions13
Lead sponsors shown5
Advertisement

Clinical trials

18 shown
A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsNCT00563368 · 2007-12-01
COMPLETED
Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsNCT00518466 · 2007-07-01
COMPLETED
Efficacy of Topiramate for Weight Loss in Subjects With Metabolic SyndromeNCT00243984 · 2005-03-01
SUSPENDED
A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or MetforminNCT00231647 · 2004-02-01
COMPLETED
An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.NCT00307619 · 2003-11-01
COMPLETED
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With ObesityNCT00210808 · 2003-09-01
COMPLETED
Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient SettingNCT00237289 · 2001-10-01
COMPLETED
A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea TherapyNCT00231634 · 2001-05-01
TERMINATED
A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaNCT00231621 · 2001-05-01
TERMINATED
A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionNCT00236665 · 2001-03-01
COMPLETED
A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietNCT00231530 · 2001-01-01
COMPLETED
A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With MetforminNCT00231660 · 2000-10-01
COMPLETED
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderNCT00240721 · 2000-10-01
COMPLETED
A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityNCT00236613 · 2000-09-01
COMPLETED
A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss ProgramNCT00236600 · 2000-08-01
COMPLETED
A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityNCT00236639 · 2000-07-01
COMPLETED
A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 DiabetesNCT00236626 · 2000-04-01
COMPLETED
A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal ObesityNCT00231608 · 1998-12-01
COMPLETED

Trial status mix

COMPLETED15
TERMINATED2
SUSPENDED1

Phase mix

PHASE313
PHASE25
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.